HOXA13 and metastatic malignant neoplasm in the lymph nodes: Analysis of the relationship between HOXA13 expression in paraffin-embedded PDAC samples and clinicopathological data indicates that patients with high HOXA13 expression exhibit increased lymph node metastasis, poor histological differentiation, and decreased overall survival (Table 1, Figure 5).